Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation

Journal article

Chen Y-L. et al, (2019), Journal of Experimental Medicine

Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis

Journal article

OGG G. et al, (2019), Science Translational Medicine

Atopic dermatitis epidemiology and unmet need in the United Kingdom.

Journal article

Cork MJ. et al, (2019), J Dermatolog Treat, 1 - 9

Capturing the antigen landscape: HLA-E, CD1 and MR1.

Journal article

Ogg G. et al, (2019), Curr Opin Immunol, 59, 121 - 129

FEVIPIPRANT INHIBITS PROSTAGLANDIN D2 MEDIATED ACTIVATION OF GROUP 2 INNATE LYMPHOID CELLS (ILC2S)

Conference paper

Sandham D. et al, (2019), RESPIROLOGY, 24, 105 - 105

Effects of Steroids in Cultured Human Type-2 Cytokine Producing Cells

Conference paper

Luo J. et al, (2018), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197

Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection

Journal article

OGG G. et al, (2018), Nature Communications

Killer T cells show their kinder side

Journal article

(2018), Nature

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Conference paper

Chen W. et al, (2018), EUROPEAN RESPIRATORY JOURNAL, 52

Type-2 CD8+T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma

Conference paper

Hinks T. et al, (2018), EUROPEAN RESPIRATORY JOURNAL, 52

Load More